Literature DB >> 18789725

Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center.

Jen-Jung Pan1, Chaoru Chen, James G Caridi, Brian Geller, Roberto Firpi, Victor I Machicao, Irvin F Hawkins, Consuelo Soldevila-Pico, David R Nelson, Giuseppe Morelli.   

Abstract

PURPOSE: This retrospective analysis was conducted to identify factors predictive of survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
MATERIALS AND METHODS: Patients who underwent TIPS creation between January 1991 and December 2005 at a tertiary-care center were identified. Log-rank tests were used to compare the cumulative survival functions among groups of patients who underwent TIPS creation for various indications. Thirty-day mortality after TIPS creation was examined by logistic regression. Cox proportional-hazards analyses were performed to analyze the cumulative 90-day and 1-year survival. Selected variables such as creatinine, bilirubin, and International Normalized Ratio (INR) were assessed with respect to survival.
RESULTS: The study included 352 patients, of whom 229 (65.1%) were male. The mean age at the time of TIPS creation was 53.6 years (range, 21-82 y). A Model for End-stage Liver Disease (MELD) score greater than 15 was significantly associated with poor survival (P < .05) at 30 days, 90 days, and 1 year after TIPS creation. Independently, a serum total bilirubin level greater than 2.5 mg/dL, an INR greater than 1.4 (P < .05), and a serum creatinine level greater than 1.2 mg/dL were predictive of poor survival. Finally, age greater than 70 years was associated with poor survival at 90 days and 1 year after TIPS creation (P < .05).
CONCLUSION: The choice to create a TIPS in individuals whose MELD score is greater than 15 and/or whose age is greater than 70 years should involve a careful consideration of risk/benefit ratio, taking into account the finding that such patients have significantly poorer survival after TIPS creation.

Entities:  

Mesh:

Year:  2008        PMID: 18789725     DOI: 10.1016/j.jvir.2008.07.021

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  9 in total

1.  Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites.

Authors:  Ahmad Parvinian; James T Bui; M Grace Knuttinen; Jeet Minocha; Ron C Gaba
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

2.  Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension.

Authors:  Sara Santos; Eduardo Dantas; Filipe Veloso Gomes; José Hugo Luz; Nuno Vasco Costa; Tiago Bilhim; Filipe Calinas; Américo Martins; Élia Coimbra
Journal:  GE Port J Gastroenterol       Date:  2020-06-09

3.  Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data.

Authors:  Hyung Ki Kim; Yoon Jun Kim; Woo Jin Chung; Soon Sun Kim; Jae Jun Shim; Moon Seok Choi; Do Young Kim; Dae Won Jun; Soon Ho Um; Sung Jae Park; Hyun Young Woo; Young Kul Jung; Soon Koo Baik; Moon Young Kim; Soo Young Park; Jae Myeong Lee; Young Seok Kim
Journal:  Clin Mol Hepatol       Date:  2014-03-26

4.  Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.

Authors:  Erin K Spengler; Lawrence G Hunsicker; Sanam Zarei; M Bridget Zimmerman; Michael D Voigt
Journal:  Hepatol Commun       Date:  2017-06-07

5.  Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older.

Authors:  Natasha Adlakha; Mark W Russo
Journal:  J Clin Med       Date:  2020-01-31       Impact factor: 4.241

6.  Renal-function change after transjugular intra-hepatic portosystemic shunt placement and its relationship with survival: a single-center experience.

Authors:  Min Lang; Angela L Lang; Brian Q Tsui; Weiping Wang; Brian K Erly; Bo Shen; Baljendra Kapoor
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-03

7.  Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.

Authors:  Justin Richard Boike; Nikhilesh Ray Mazumder; Kanti Pallav Kolli; Jin Ge; Margarita German; Nathaniel Jest; Giuseppe Morelli; Erin Spengler; Adnan Said; Jennifer C Lai; Archita P Desai; Thomas Couri; Sonali Paul; Catherine Frenette; Elizabeth C Verna; Usman Rahim; Aparna Goel; Dyanna Gregory; Bartley Thornburg; Lisa B VanWagner
Journal:  Am J Gastroenterol       Date:  2021-10-01       Impact factor: 12.045

8.  Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy.

Authors:  Hong-Bin Li; Zhen-Dong Yue; Hong-Wei Zhao; Lei Wang; Zhen-Hua Fan; Fu-Liang He; Xiao-Qun Dong; Fu-Quan Liu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-07-16

Review 9.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.